UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Circulation (New York, N.Y.), 2017-12, Vol.136 (25), p.2420-2436

2017

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e273-e280

2015

Volltextzugriff (PDF)

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry

Circulation (New York, N.Y.), 2013-05, Vol.127 (20), p.2021-2030

2013

Volltextzugriff (PDF)

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy

Circulation (New York, N.Y.), 2003-06, Vol.107 (23), p.2872-2875

2003

Volltextzugriff (PDF)

Controversies in cardiovascular medicine revisited

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1561-1561

Estes, 3rd, N A Mark

2014

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement”

Circulation (New York, N.Y.), 2016-03, Vol.133 (11), p.e437-e438

2016

Volltextzugriff (PDF)

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Circulation (New York, N.Y.), 2016-04, Vol.133 (14), p.e506-e574

2016

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e315-e325

2015

Volltextzugriff (PDF)

Survival of the Fittest: Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction

Circulation (New York, N.Y.), 2014-08, Vol.130 (9), p.737-739

Mark Estes, N.A

2014

Volltextzugriff (PDF)

Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement From the American Heart Association

Circulation (New York, N.Y.), 2010-01, Vol.121 (3), p.458-477

2010

Volltextzugriff (PDF)

Interpretation of the Electrocardiogram of Young Athletes

Circulation (New York, N.Y.), 2011-08, Vol.124 (6), p.746-757

2011

Volltextzugriff (PDF)

Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/ Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia

Circulation (New York, N.Y.), 2010-09, Vol.122 (12), p.1144-1152

2010

Volltextzugriff (PDF)

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Circulation (New York, N.Y.), 2016-04, Vol.133 (14), p.e471-e505

2016

Volltextzugriff (PDF)

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons

Circulation (New York, N.Y.), 2008-05, Vol.117 (21), p.e350-e408

2008

Volltextzugriff (PDF)

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology

Circulation (New York, N.Y.), 2015-12, Vol.132 (22), p.e334-e338

2015

Volltextzugriff (PDF)

Sudden Cardiac Death in the Athlete: Bridging the Gaps Between Evidence, Policy, and Practice

Circulation (New York, N.Y.), 2012-05, Vol.125 (20), p.2511-2516

2012

Volltextzugriff (PDF)

American Heart Association Response to the 2015 Institute of Medicine Report on Strategies to Improve Cardiac Arrest Survival

Circulation (New York, N.Y.), 2015-09, Vol.132 (11), p.1049-1070

2015

Volltextzugriff (PDF)

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Circulation (New York, N.Y.), 2011-01, Vol.123 (1), p.104-123

2011

Volltextzugriff (PDF)

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Circulation (New York, N.Y.), 2011-03, Vol.123 (10), p.1144-1150

2011

Volltextzugriff (PDF)

Predicting and Preventing Sudden Cardiac Death

Circulation (New York, N.Y.), 2011-08, Vol.124 (5), p.651-656

ESTES, N. A. Mark

2011

Volltextzugriff (PDF)

Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study

Circulation (New York, N.Y.), 2024-08, Vol.150 (7), p.516-530

2024

Volltextzugriff (PDF)

Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

Circulation (New York, N.Y.), 2003-12, Vol.108 (25), p.3084-3091

2003

Volltextzugriff (PDF)

The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction

Circulation (New York, N.Y.), 2009-07, Vol.120 (3), p.185-187

Estes, 3rd, N A Mark

2009

Volltextzugriff (PDF)

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases

Circulation (New York, N.Y.), 2004-06, Vol.109 (22), p.2807-2816

2004

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(67)
Reviews
(1)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(68)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(68)
Ingenta
(54)
MEDLINE
(51)
IngentaConnect Journals
(50)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy

Controversies in cardiovascular medicine revisited

Response to Letter Regarding Article, “Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement”

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology

Survival of the Fittest: Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction

2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Update on Cardiovascular Implantable Electronic Device Infections and Their Management: A Scientific Statement From the American Heart Association

Interpretation of the Electrocardiogram of Young Athletes

Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/ Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Sudden Cardiac Death in the Athlete: Bridging the Gaps Between Evidence, Policy, and Practice

American Heart Association Response to the 2015 Institute of Medicine Report on Strategies to Improve Cardiac Arrest Survival

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Predicting and Preventing Sudden Cardiac Death

Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study

Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases

Aktive Filter

Suchergebnisse filtern